Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000169245 | SCV000220524 | likely pathogenic | Pendred syndrome | 2014-07-17 | criteria provided, single submitter | literature only | |
Division of Hearing and Balance Research, |
RCV000515737 | SCV000611821 | pathogenic | Autosomal recessive nonsyndromic hearing loss 4 | 2017-07-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001048975 | SCV001213005 | pathogenic | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 659 of the SLC26A4 protein (p.Val659Leu). This variant is present in population databases (rs200455203, gnomAD 0.02%). This missense change has been observed in individual(s) with enlarged vestibular aqueduct (PMID: 17443271, 21366435, 21961810, 22289209, 23385134, 25266519, 25372295, 26100058). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 188889). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SLC26A4 protein function. For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV000515737 | SCV002026959 | pathogenic | Autosomal recessive nonsyndromic hearing loss 4 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000169245 | SCV002026960 | pathogenic | Pendred syndrome | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001048975 | SCV003821119 | pathogenic | not provided | 2022-06-10 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000515737 | SCV004201868 | pathogenic | Autosomal recessive nonsyndromic hearing loss 4 | 2023-09-11 | criteria provided, single submitter | clinical testing | |
Genetic Testing Center for Deafness, |
RCV000515737 | SCV000902378 | likely pathogenic | Autosomal recessive nonsyndromic hearing loss 4 | 2019-02-26 | no assertion criteria provided | case-control | |
National Institute of Sensory Organs, |
RCV000515737 | SCV000994902 | affects | Autosomal recessive nonsyndromic hearing loss 4 | 2019-08-20 | no assertion criteria provided | clinical testing | in vitro experiment |